Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1786.7

7 hours ago
share
Share Via
With a 67.3% gain over the past year, Tatva Chintan Pharma Chem Ltd has surged to a fresh 52-week high of Rs 1786.7 on 21 Jul 2026, outpacing the Sensex which declined 5.6% over the same period. This milestone reflects a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum.
Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1786.7

Stock Performance and Price Movement

On 21 Jul 2026, Tatva Chintan Pharma Chem Ltd’s share price touched an intraday high of Rs.1786.7, representing a 4.24% increase from the previous close. Despite this strong intraday surge, the stock closed with a modest day change of 0.32%, slightly underperforming its sector by 0.56%. The day’s trading range was marked by a low of Rs.1678.55, down 2.07% from the prior session, indicating some volatility during the trading day.

The stock’s new 52-week high stands well above its 52-week low of Rs.977.85, underscoring a robust upward trajectory over the past year. This translates to a one-year price appreciation of 67.32%, significantly outperforming the broader Sensex index, which declined by 5.56% over the same period.

Technical Indicators and Trend Analysis

From a technical standpoint, Tatva Chintan Pharma Chem Ltd is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment typically signals a strong bullish trend and sustained investor confidence in the stock’s price direction.

Weekly and monthly technical indicators present a predominantly bullish outlook. The Moving Average Convergence Divergence (MACD) is bullish on both weekly and monthly charts, while Bollinger Bands also indicate bullish momentum. The Know Sure Thing (KST) oscillator and Dow Theory assessments show mild to strong bullish signals on weekly and monthly timeframes. However, the daily moving averages suggest a mildly bearish stance, reflecting some short-term consolidation following recent gains.

Relative Strength Index (RSI) readings on weekly and monthly charts do not currently signal overbought or oversold conditions, suggesting the stock’s price movement remains within a balanced range. On-Balance Volume (OBV) trends are neutral weekly but mildly bullish monthly, indicating moderate accumulation over a longer horizon.

Market Context and Sector Comparison

The broader market environment on 21 Jul 2026 was subdued, with the Sensex opening flat and trading slightly lower by 0.14% at 77,603.04 points. The index remains above its 50-day moving average, although the 50-day average itself is positioned below the 200-day moving average, reflecting some mixed signals in the broader market trend.

Within the specialty chemicals sector, Tatva Chintan Pharma Chem Ltd’s performance stands out due to its strong price appreciation and technical positioning. Despite the sector’s overall modest movement, the stock’s ability to reach a new 52-week high highlights its relative strength and resilience.

Mojo Score and Rating Update

MarketsMOJO assigns Tatva Chintan Pharma Chem Ltd a Mojo Score of 62.0, categorising the stock with a 'Hold' grade as of 13 Jul 2026. This represents an upgrade from the previous 'Sell' rating, reflecting improved fundamentals and technical outlook. The company is classified as a small-cap within the specialty chemicals industry, which often entails higher volatility but also potential for significant price movements.

The upgrade in rating coincides with the stock’s recent price strength and technical improvements, signalling a more stable outlook compared to prior assessments.

Summary of Key Metrics

To summarise, Tatva Chintan Pharma Chem Ltd’s key data points as of 21 Jul 2026 are:

  • New 52-week high price: Rs.1786.7
  • One-year price gain: 67.32%
  • 52-week low price: Rs.977.85
  • Day’s intraday range: Rs.1678.55 to Rs.1786.7
  • Day change: +0.32%
  • Sector performance comparison: Underperformed by 0.56% on the day
  • Mojo Score: 62.0 (Hold rating, upgraded from Sell)
  • Market capitalisation: Small-cap

Conclusion

Tatva Chintan Pharma Chem Ltd’s attainment of a new 52-week high at Rs.1786.7 marks a significant milestone in its market journey. Supported by strong technical indicators and a positive rating revision, the stock has demonstrated considerable resilience and momentum within the specialty chemicals sector. While the broader market showed modest weakness on the day, Tatva Chintan’s price action reflects sustained investor interest and underlying strength over the past year.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News